Abses Payudara
Published on May 15, 2026
Risk Factors
Lactating women (puerperal abscess), smoking, diabetes mellitus, obesity, nipple piercing, prior breast surgery, periductal mastitis in non-lactating women
Etiology
Staphylococcus aureus (most common, including MRSA); polymicrobial in non-lactating or recurrent cases; arises from untreated or inadequately treated lactational mastitis or periductal inflammation
Presentation
Painful, swollen breast mass with overlying erythema and warmth; may report fever, malaise; lactating women often present 2-6 weeks postpartum
Classic Exam
Fluctuant, tender, well-circumscribed mass with surrounding cellulitis; overlying skin may appear shiny or thinned; axillary lymphadenopathy possible; may have spontaneous purulent nipple discharge or cutaneous fistula in periductal type
Diagnostics
Ultrasound shows hypoechoic fluid collection with internal debris and peripheral vascularity; needle aspiration yields purulent material; culture and sensitivity guide antibiotic therapy
Management
Incision and drainage (I&D) or ultrasound-guided needle aspiration + culture-directed antibiotics; continue breastfeeding on the affected side when possible
Keywords
"Fluctuant breast mass," "lactating woman with fever," "failed course of antibiotics for mastitis," "purulent aspirate," "postpartum breast pain with palpable collection"
01Pathophysiology
A breast abscess represents a localized collection of pus within the breast parenchyma. The mechanism differs based on whether the patient is lactating or not.
In lactational (puerperal) abscess, the sequence begins with milk stasis. When milk is inadequately drained from the breast, it accumulates within the ducts and creates a favorable medium for bacterial growth. Bacteria, most commonly Staphylococcus aureus, enter through microscopic skin breaks or fissures on the nipple surface that occur during breastfeeding. The resulting infection first manifests as mastitis (diffuse cellulitis of the breast tissue). If mastitis is not treated promptly or does not respond to antibiotics, the infection becomes walled off by an inflammatory capsule, forming a true abscess. This encapsulation is the reason antibiotics alone cannot resolve an established abscess, as the drug cannot penetrate a mature abscess wall at therapeutic concentrations.
In non-lactational abscess, the pathogenesis is different. The most common subtype is periductal (periareolar) abscess, strongly associated with smoking. Smoking causes squamous metaplasia of the lactiferous duct epithelium, replacing the normal columnar lining. This metaplastic epithelium produces keratin plugs that obstruct the duct, leading to duct ectasia, secondary bacterial infection, and abscess formation. The microbiology in non-lactating patients tends to be polymicrobial, often involving anaerobes and mixed skin flora. This is why recurrence is common in smokers who continue the habit.
Understanding this distinction is important because the test frequently presents a non-lactating woman with a periareolar mass and asks you to identify the risk factor (smoking) or the underlying histologic change (squamous metaplasia).
02Classification and Clinical Manifestation
Lactational (Puerperal)
Population
Breastfeeding women, typically 2-6 weeks postpartum
Location
Peripheral breast parenchyma, often unilateral
Microbiology
S. aureus (including MRSA), S. epidermidis, streptococci
Clinical Features
Painful, erythematous, fluctuant mass; fever; history of cracked nipples or incomplete milk drainage
Recurrence Risk
Low if breastfeeding technique is corrected
Non-lactational Periductal (Periareolar)
Population
Smokers, typically younger non-lactating women
Location
Central/periareolar region
Microbiology
Polymicrobial: anaerobes (Bacteroides, Peptostreptococcus), mixed aerobes
Clinical Features
Periareolar mass, may form mammary duct fistula; recurrent episodes common
Recurrence Risk
High, especially if smoking continues
Non-lactational Peripheral
Population
Diabetes mellitus, immunosuppression, obesity, rheumatoid arthritis (on steroids)
Location
Peripheral breast
Microbiology
Mixed organisms, gram-negatives possible
Clinical Features
Resembles lactational type but without breastfeeding history; may be indolent
Recurrence Risk
Moderate; depends on control of underlying comorbidity
Secondary Abscess
Population
Any population
Location
Variable
Microbiology
Depends on primary pathology
Clinical Features
Develops secondary to an underlying lesion (granulomatous mastitis, foreign body, infected cyst, or rarely inflammatory carcinoma)
Recurrence Risk
Depends on treatment of the underlying cause
Type | Population | Location | Microbiology | Clinical Features | Recurrence Risk |
|---|---|---|---|---|---|
Lactational (Puerperal) | Breastfeeding women, typically 2-6 weeks postpartum | Peripheral breast parenchyma, often unilateral | S. aureus (including MRSA), S. epidermidis, streptococci | Painful, erythematous, fluctuant mass; fever; history of cracked nipples or incomplete milk drainage | Low if breastfeeding technique is corrected |
Non-lactational Periductal (Periareolar) | Smokers, typically younger non-lactating women | Central/periareolar region | Polymicrobial: anaerobes (Bacteroides, Peptostreptococcus), mixed aerobes | Periareolar mass, may form mammary duct fistula; recurrent episodes common | High, especially if smoking continues |
Non-lactational Peripheral | Diabetes mellitus, immunosuppression, obesity, rheumatoid arthritis (on steroids) | Peripheral breast | Mixed organisms, gram-negatives possible | Resembles lactational type but without breastfeeding history; may be indolent | Moderate; depends on control of underlying comorbidity |
Secondary Abscess | Any population | Variable | Depends on primary pathology | Develops secondary to an underlying lesion (granulomatous mastitis, foreign body, infected cyst, or rarely inflammatory carcinoma) | Depends on treatment of the underlying cause |
A key clinical pearl: when a non-lactating, non-smoking older woman presents with a breast abscess, especially one that is recurrent or does not heal after standard treatment, always consider inflammatory breast carcinoma as a potential underlying cause. The test uses this scenario to assess whether students reflexively treat the abscess without pursuing further workup.
03Diagnostic Workup
Breast ultrasound
Role
Best initial test
Key Findings
Hypoechoic or anechoic fluid collection with irregular walls, internal echoes/debris, and increased peripheral vascularity on Doppler
Needle aspiration (diagnostic + therapeutic)
Role
Confirms diagnosis and provides culture material
Key Findings
Purulent aspirate; send for Gram stain, culture, and sensitivity
Culture and sensitivity
Role
Guides targeted antibiotic therapy
Key Findings
Identifies organism and resistance pattern (critical for MRSA-endemic areas)
Mammography
Role
Not first-line for acute abscess; used after resolution in women over 40 or with atypical features
Key Findings
Rule out underlying malignancy; difficult to interpret during active infection
Core needle biopsy
Role
When malignancy is suspected
Key Findings
Indicated if mass persists after drainage, in non-lactating older women, or if imaging is atypical
Test | Role | Key Findings |
|---|---|---|
Breast ultrasound | Best initial test | Hypoechoic or anechoic fluid collection with irregular walls, internal echoes/debris, and increased peripheral vascularity on Doppler |
Needle aspiration (diagnostic + therapeutic) | Confirms diagnosis and provides culture material | Purulent aspirate; send for Gram stain, culture, and sensitivity |
Culture and sensitivity | Guides targeted antibiotic therapy | Identifies organism and resistance pattern (critical for MRSA-endemic areas) |
Mammography | Not first-line for acute abscess; used after resolution in women over 40 or with atypical features | Rule out underlying malignancy; difficult to interpret during active infection |
Core needle biopsy | When malignancy is suspected | Indicated if mass persists after drainage, in non-lactating older women, or if imaging is atypical |
Breast ultrasound is the best initial test. It confirms the presence of a drainable fluid collection, distinguishes abscess from cellulitis without a drainable component (mastitis alone), and can guide percutaneous needle aspiration. On ultrasound, a mature abscess appears as a hypoechoic lesion with thick, irregular walls and internal debris. Color Doppler shows increased vascularity in the surrounding inflamed tissue.
The distinction between mastitis and abscess is tested frequently. Mastitis presents as diffuse breast erythema, pain, and fever without a discrete fluctuant mass, and it responds to antibiotics alone. An abscess has a palpable fluctuant collection that requires drainage. When the clinical exam is equivocal, ultrasound is the deciding study.
Aspirated material must always be sent for culture and sensitivity. This is not optional. The rising prevalence of community-acquired MRSA means empiric coverage must account for resistance, and culture results allow de-escalation or adjustment. Gram stain provides rapid preliminary information.
In patients over 40 or those with features raising concern for malignancy (skin dimpling, bloody discharge, non-resolving mass), mammography and/or core biopsy should be performed after the acute infection resolves. Performing mammography during active infection is unreliable and painful.
04Management and Treatment
Small abscess (< 3 cm)
Management
Ultrasound-guided needle aspiration + oral antibiotics
Details
Aspirate to dryness; may require repeat aspiration in 2-3 days if reaccumulates
Large abscess (>= 3 cm) or failed aspiration
Management
Incision and drainage (I&D) + oral or IV antibiotics
Details
Pack wound loosely; allow healing by secondary intention
Empiric antibiotics (outpatient, lactational)
Management
Dicloxacillin 500 mg PO q6h x 10-14 days OR cephalexin 500 mg PO q6h
Details
Covers methicillin-sensitive S. aureus
MRSA suspected or confirmed
Management
Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 DS tablets PO q12h x 10-14 days OR clindamycin 300 mg PO q6h
Details
TMP-SMX is safe during breastfeeding; clindamycin is an alternative
Severe/hospitalized patients
Management
IV vancomycin 15-20 mg/kg q8-12h
Details
For systemically ill patients, failed outpatient therapy, or confirmed MRSA with severe infection
Non-lactational periductal
Management
Drainage + antibiotics covering anaerobes (amoxicillin-clavulanate 875/125 mg PO q12h or metronidazole 500 mg PO q8h added to standard coverage)
Details
Must include anaerobic coverage due to polymicrobial etiology
Breastfeeding
Management
Continue nursing or pumping on the affected side
Details
Milk is not harmful to the infant; continued drainage prevents worsening stasis
Clinical Scenario | Management | Details |
|---|---|---|
Small abscess (< 3 cm) | Ultrasound-guided needle aspiration + oral antibiotics | Aspirate to dryness; may require repeat aspiration in 2-3 days if reaccumulates |
Large abscess (>= 3 cm) or failed aspiration | Incision and drainage (I&D) + oral or IV antibiotics | Pack wound loosely; allow healing by secondary intention |
Empiric antibiotics (outpatient, lactational) | Dicloxacillin 500 mg PO q6h x 10-14 days OR cephalexin 500 mg PO q6h | Covers methicillin-sensitive S. aureus |
MRSA suspected or confirmed | Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 DS tablets PO q12h x 10-14 days OR clindamycin 300 mg PO q6h | TMP-SMX is safe during breastfeeding; clindamycin is an alternative |
Severe/hospitalized patients | IV vancomycin 15-20 mg/kg q8-12h | For systemically ill patients, failed outpatient therapy, or confirmed MRSA with severe infection |
Non-lactational periductal | Drainage + antibiotics covering anaerobes (amoxicillin-clavulanate 875/125 mg PO q12h or metronidazole 500 mg PO q8h added to standard coverage) | Must include anaerobic coverage due to polymicrobial etiology |
Breastfeeding | Continue nursing or pumping on the affected side | Milk is not harmful to the infant; continued drainage prevents worsening stasis |
Acute management centers on source control. An abscess is a surgical disease in the sense that antibiotics alone cannot cure an established collection. The principle is straightforward: if there is pus, it must be drained.
For abscesses smaller than 3 cm, ultrasound-guided needle aspiration is preferred as the initial approach. It is less invasive, avoids a scar on the breast, and has comparable success rates for smaller collections. The cavity is aspirated to dryness, and the procedure may need to be repeated once or twice if the fluid reaccumulates. If the abscess does not resolve after 2-3 aspirations, formal I&D is indicated.
For abscesses 3 cm or larger, or those with overlying skin necrosis, I&D is the standard approach. The wound is left open and packed loosely, healing by secondary intention. Premature closure risks reaccumulation.
Antibiotic selection depends on the clinical context. In lactational abscess, the dominant organism is S. aureus, so empiric therapy targets staphylococci. In communities with high MRSA prevalence (>10-15%), empiric MRSA coverage with TMP-SMX or clindamycin is appropriate. For non-lactational periductal abscess, anaerobic coverage must be added because the flora is polymicrobial.
A frequently tested point: breastfeeding should not be discontinued. Continued nursing or pumping from the affected breast promotes drainage, reduces stasis, and does not transmit infection to the infant. The only exception is if the incision or drain site is so close to the areola that the infant would directly contact the wound.
For recurrent periductal abscess, definitive treatment requires excision of the involved duct (central duct excision) once the acute infection resolves. Without this, the cycle of obstruction and infection will repeat. Smoking cessation is also an integral part of long-term management.
05Differential Diagnosis and Distractors
Lactational mastitis
Why It Is Similar
Also presents with breast pain, erythema, and fever in a breastfeeding woman
Key Discriminator
No discrete fluctuant mass or fluid collection on ultrasound; responds to antibiotics alone without drainage
Inflammatory breast carcinoma
Why It Is Similar
Erythema, warmth, skin thickening (peau d'orange), and breast enlargement can mimic infection
Key Discriminator
No fever or leukocytosis typically; does not improve with antibiotics; skin biopsy shows dermal lymphatic invasion by tumor cells; suspect in non-lactating older women
Fat necrosis
Why It Is Similar
Firm, irregular breast mass that can appear concerning on exam and imaging
Key Discriminator
History of trauma or prior surgery; mammogram shows oil cyst or rim calcification; painless or mildly tender; no systemic signs of infection
Granulomatous mastitis
Why It Is Similar
Painful breast mass, may suppurate and form sinus tracts; mimics abscess clinically
Key Discriminator
Often bilateral or recurrent; biopsy shows non-caseating granulomas; cultures negative; associated with recent pregnancy or autoimmune conditions
Phyllodes tumor
Why It Is Similar
Rapidly enlarging breast mass that may outgrow its blood supply and become necrotic, mimicking an abscess
Key Discriminator
Smooth, well-circumscribed mass on imaging; ultrasound shows solid lesion (not fluid collection); biopsy shows fibroepithelial neoplasm with leaf-like architecture
Breast cyst (infected)
Why It Is Similar
Tender, fluid-filled breast lesion with surrounding inflammation
Key Discriminator
Simple cyst on prior imaging; aspirate is turbid but not frankly purulent; no surrounding cellulitis unless secondarily infected
Differential Diagnosis | Why It Is Similar | Key Discriminator |
|---|---|---|
Lactational mastitis | Also presents with breast pain, erythema, and fever in a breastfeeding woman | No discrete fluctuant mass or fluid collection on ultrasound; responds to antibiotics alone without drainage |
Inflammatory breast carcinoma | Erythema, warmth, skin thickening (peau d'orange), and breast enlargement can mimic infection | No fever or leukocytosis typically; does not improve with antibiotics; skin biopsy shows dermal lymphatic invasion by tumor cells; suspect in non-lactating older women |
Fat necrosis | Firm, irregular breast mass that can appear concerning on exam and imaging | History of trauma or prior surgery; mammogram shows oil cyst or rim calcification; painless or mildly tender; no systemic signs of infection |
Granulomatous mastitis | Painful breast mass, may suppurate and form sinus tracts; mimics abscess clinically | Often bilateral or recurrent; biopsy shows non-caseating granulomas; cultures negative; associated with recent pregnancy or autoimmune conditions |
Phyllodes tumor | Rapidly enlarging breast mass that may outgrow its blood supply and become necrotic, mimicking an abscess | Smooth, well-circumscribed mass on imaging; ultrasound shows solid lesion (not fluid collection); biopsy shows fibroepithelial neoplasm with leaf-like architecture |
Breast cyst (infected) | Tender, fluid-filled breast lesion with surrounding inflammation | Simple cyst on prior imaging; aspirate is turbid but not frankly purulent; no surrounding cellulitis unless secondarily infected |
06Traps and High-Yield Pearls
The most common way students lose points on breast abscess questions is by selecting antibiotics alone as the answer when a drainable collection is present. The moment the vignette describes a "fluctuant mass" or ultrasound shows a fluid collection with debris, the answer must include drainage (either aspiration or I&D). Antibiotics without source control will not resolve a walled-off abscess.
The second classic trap is the non-lactating woman whose abscess does not resolve. If the vignette describes a breast abscess in an older, non-breastfeeding woman that persists despite adequate drainage and antibiotics, the next best step is tissue biopsy to rule out inflammatory breast carcinoma. Students who anchor on the infectious diagnosis and simply repeat drainage will miss the underlying malignancy.
Another commonly tested concept is the instruction to continue breastfeeding. The vignette may frame this as a follow-up question: "What do you advise the patient regarding breastfeeding?" The correct answer is to continue, not to stop. Stopping breastfeeding worsens milk stasis and paradoxically promotes abscess progression.
Finally, remember the smoking-squamous metaplasia-periductal abscess triad for non-lactating patients. When the question stem mentions a young female smoker with a recurrent periareolar mass, the underlying mechanism being tested is squamous metaplasia of the lactiferous ducts, and definitive management includes duct excision and smoking cessation.